Bristol Myers Squibb stock rises, Merck moves lower. Here’s why.
Pharmaceutical giant Bristol Myers Squibb (BMY) raises its full-year earnings guidance after topping third quarter estimates, sending shares higher in pre-market trading. Concurrently, Merck & Co. (MRK) lowered its sales outlook despite topping third quarter estimates, sending the stock lower. Julie Hyman and Brad Smith report more on these two pharma companies’ earnings results tied…